4 completed. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
Follow pegvaliase: new trials by email Literature Review of pegvaliase trials Research Report on pegvaliase
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate Subcutaneously Administered rAvPAL-PEG in Patients With Phenylketonuria for 24 Weeks BMN 165 (rAvPAL-PEG) - Phenylketonuria | Phase 2 | Completed | BioMarin Pharmaceutical | 24 | 2012-05-01 | 2019-08-06 |
| Safety, Tolerability, and Efficacy Study of rAvPAL-PEG Administered Daily in Subjects With Phenylketonuria (PKU) rAvPAL-PEG - Phenylketonuria | Phase 2 | Completed | BioMarin Pharmaceutical | 16 | 2011-03-01 | 2019-02-26 |
| Long-Term Extension of Previous rAvPAL-PEG Protocols in Subjects With PKU (PAL-003) rAvPAL-PEG - Phenylketonuria | Phase 2 | Completed | BioMarin Pharmaceutical | 68 | 2010-01-13 | 2021-10-12 |
| Dose-Finding Study to Evaluate the Safety, Efficacy, & Tolerability of Multiple Doses of rAvPAL-PEG in Subjects With PKU rAvPAL-PEG 0.001 mg/kg, rAvPAL-PEG 0.003 mg/kg, rAvPAL-PEG 0.01 mg/kg - Phenylketonuria | Phase 2 | Completed | BioMarin Pharmaceutical | 40 | 2009-09-01 | 2019-02-26 |
Phenylketonurias (4)
United States (4)
Ari Gershman, MD (2) · Debra Lounsbury (1)